Back

Patients' perspective on a pill-in-the-pocket oral anticoagulation as an alternative stroke prevention strategy in atrial fibrillation

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePosters Day 2 Oral Anticoagulation EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Andre Briosa E Gala

Bern University Hospital, Inselspital, Bern (Switzerland)

131 More presentations in this session

Presentation thumbnail
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract Slides
Presentation thumbnail
Pure and impure tachycardiomiopathy: key differences and long term prognosis
Doctor G. Stronati (Ancona, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation
Professor D. Lashkul (Zaporizhzhya, UA)
Abstract Slides
Presentation thumbnail
Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults
Mr E. Abdovic (Zenica, BA)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score and the risk of death in atrial fibrillation
Doctor A. Aro (Helsinki, FI)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 2

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources